Increase in bids raises hopes of a rise in UK M&A work
M&A partners are predicting that the UK could soon see an increase in lucrative hostile takeovers after the first five months of this year saw unsolicited bids globally hit their highest value since May 2007, standing at a total of $273.4bn.
Bids, whether pending, completed, withdrawn or rejected, are up significantly on the $70.6bn announced in 2013, according to figures from Dealogic, largely driven by Pfizer’s unsuccessful $122.6bn approach for the UK’s AstraZeneca, announced on 2 May, in what is the third largest hostile M&A bid on record.
Subscriber Access
You must be logged in to view full premium content.
